Jorn Aldag - Feb 1, 2022 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role
Chief Executive Officer, Director
Signature
/s/ Reinhard Kandera, as Attorney-in-Fact
Stock symbol
HOOK
Transactions as of
Feb 1, 2022
Transactions value $
$263,031
Form type
4
Date filed
2/1/2022, 07:44 PM
Next filing
Apr 20, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HOOK Common Stock Award $143K +47.8K +1158.53% $3.00 52K Feb 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOOK Stock Option (Right to Buy) Award $120K +39.9K $3.00 39.9K Feb 1, 2022 Common Stock 39.9K $1.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was awarded 47,824 unrestricted shares of common stock as a portion of their base salary for the six month ending June 30, 2022.
F2 This stock option is fully vested.